John Theurer Cancer Center at Hackensack University Medical Center is a clinical research site located in Hackensack, New Jersey, United States 07601.
Crixeo Clinical Trials Trust Score: 91/100 (GOOD). This profile has not yet been claimed by the site owner.
John Theurer Cancer Center at Hackensack University Medical Center has participated in 173 clinical trials with 68 currently active.
Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Hepatocellular Carcinoma (HCC), Cancer Related Cognitive Decline.
Sponsors: Pfizer, Bristol-Myers Squibb, Georgetown University.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Hackensack
Trust Score: 91/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
John Theurer Cancer Center at Hackensack University Medical Center has a Crixeo Trust Score of 91/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
John Theurer Cancer Center at Hackensack University Medical Center has 173 clinical trials on record, with 68 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Hepatocellular Carcinoma (HCC), Cancer Related Cognitive Decline.
John Theurer Cancer Center at Hackensack University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.